KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Other Non-Current Liabilities (2016 - 2021)

Abbott Laboratories (ABT) has disclosed Other Non-Current Liabilities for 13 consecutive years, with $3.7 billion as the latest value for Q4 2021.

  • Quarterly Other Non-Current Liabilities changed 0.03% to $3.7 billion in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $3.7 billion through Dec 2021, changed 0.03% year-over-year, with the annual reading at $3.7 billion for FY2021, 0.03% changed from the prior year.
  • Other Non-Current Liabilities hit $3.7 billion in Q4 2021 for Abbott Laboratories, roughly flat from $3.7 billion in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $4.9 billion in Q4 2017 to a low of $3.7 billion in Q4 2020.
  • Historically, Other Non-Current Liabilities has averaged $4.0 billion across 5 years, with a median of $3.9 billion in 2019.
  • Biggest five-year swings in Other Non-Current Liabilities: skyrocketed 138.11% in 2017 and later decreased 17.94% in 2018.
  • Year by year, Other Non-Current Liabilities stood at $4.9 billion in 2017, then fell by 17.94% to $4.0 billion in 2018, then fell by 1.0% to $3.9 billion in 2019, then decreased by 6.59% to $3.7 billion in 2020, then rose by 0.03% to $3.7 billion in 2021.
  • Business Quant data shows Other Non-Current Liabilities for ABT at $3.7 billion in Q4 2021, $3.7 billion in Q4 2020, and $3.9 billion in Q4 2019.